Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Hepatocellular

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

182 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Completed

Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma

NCT01003015

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Regensburg, Bavaria, Germany

Frankfurt am Main, Hesse, Germany

Essen, North Rhine-Westphalia, Germany

Mainz, Rhineland-Palatinate, Germany

View all 13 locations

View Trial Details

Completed

Testing of ADI-PEG in Hepatocellular Carcinoma

NCT00056992

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: MD Anderson Cancer center Houston, Texas, United States

View Trial Details

Completed

Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan

NCT01411436

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Many Locations, Japan

View Trial Details

Completed

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

NCT00355355

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: University Hospital Dubrava Zagreb, Croatia

Tuen Mun Hospital Tuenmen, New Territories, Hong Kong

Prince of Wales Hospital, Dept. of Clincal Oncology New Territories, Hong Kong

Dr. Kamakshi Memorial Hospital Chennai, India

View all 34 locations

View Trial Details

Completed

A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma

NCT00108953

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Birmingham, Alabama, United States

Beverly Hills, California, United States

Orange, California, United States

Palo Alto, California, United States

View all 28 locations

View Trial Details

Completed

A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT00105443

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Phoenix, Arizona, United States

Tucson, Arizona, United States

Los Angeles, California, United States

Los Angeles, California, United States

View all 178 locations

View Trial Details

Completed

INSIGHT - Post Marketing Surveillance

NCT00792350

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Many Locations, Austria

Many Locations, Germany

View Trial Details

Completed

A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

NCT00492752

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Hefei, Anhui, China

Guangzhou, Guangdong, China

Guangzhou, Guangdong, China

Wuhan, Hubei, China

View all 23 locations

View Trial Details

Completed

A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma

NCT00044512

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Los Angeles, California, United States

New York, United States

Bruxelles - Brussel, Belgium

Bruxelles - Brussel, Belgium

View all 23 locations

View Trial Details

Completed

Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma

NCT01096914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Liver Unit - Cardarelli Hospital Naples, Italy

View Trial Details